… -CRC effector T cells is the administration of dendritic cell-based vaccines. In this method,
dendritic cells are harvested and treated ex vivo to display tumor-specific peptides. Then, the …

… alone or combined with tumor lysate-pulsed condition, but … Dendritic cell-based vaccines
still fail to reach the theoretical … (A) Tumor volume of CT26 cell syngeneic colorectal cancer …

… and RFA or percutaneous ethanol injection (PEI) in prolonging … Colorectal cancer is one of
the most common type of cancer, 2 … After non-melanocytic skin cancer (NMSC), lung cancer is …

… cancer vaccines, including dendritic cells, RNA, DNA … , hepatocellular carcinoma, and
colorectal carcinoma [46]. Similarly, … primed with tumor lysate-pulsed dendritic cells [88]. The …

… -in-human phase I/II study to investigate an off-the-shelf vaccination, … Vaccination of
advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial …

… sense to include dendritic cell vaccines, in situ vaccination, and vaccination in ex … vaccine
targeting non-mutated TAAs was tested in advanced melanoma patients in a Phase I study [118…

… in combination with chemotherapy with or without dendritic cell (DC) infusions, were included
in … therapy of intratumoral injection of recombinant virus and intravenous injection of CIK …

… studies to design potential tumor vaccines [40]. Among these EVs, a relatively large focus
has been put on dendritic cells (… to be safe and effective in metastatic melanoma participants (…

… inherited from tumor lysate–pulsed dendritic cell. When … , including cancer vaccines and
adoptive cell therapies (ACT)… solid tumors such as lung cancer, melanoma, and colorectal …

… Dendritic cells (DCs) are antigen presenting cells (APCs) … with a better prognosis in colorectal
carcinoma, suggesting an … Patients who received autologous tumour lysate pulsed DCs …